about
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP aut...
Read More
1.11
0.00
(0.00%)
43,496.0
XNAS Volume
High vol. this week
XNAS 12 May, 2026 10:35 AM (EDT)
Board Meeting
The next board meeting for BioCardia Inc is on 14 May 2026 for the purpose of BioCardia Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
BioCardia Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..